| Literature DB >> 32096361 |
Jihoon Kim1, Joo Myung Lee2, Seung Hyuk Choi3, Ki Hong Choi1, Taek Kyu Park1, Sung Ji Park4, Jeong Hoon Yang1, Young Bin Song1, Joo Yong Hahn1, Mi Ja Jang5, Bon Kwon Koo6, Hyeon Cheol Gwon1.
Abstract
BACKGROUND AND OBJECTIVES: Although percutaneous coronary intervention (PCI) is recommended to improve symptoms in patients with stable ischemic heart disease (SIHD), improvement of exercise performance is controversial. This study aimed to investigate changes in exercise duration after PCI according to functional completeness of revascularization by comparing pre- and post-PCI exercise stress test (EST).Entities:
Keywords: Chronic stable angina; Exercise; Percutaneous coronary intervention; Prognosis
Year: 2020 PMID: 32096361 PMCID: PMC7098823 DOI: 10.4070/kcj.2019.0319
Source DB: PubMed Journal: Korean Circ J ISSN: 1738-5520 Impact factor: 3.243
Baseline clinical characteristics
| Variables | Functional CR group (n=149) | Functional IR group (n=107) | p value | |
|---|---|---|---|---|
| Age (years) | 58.0 (51.0–66.0) | 60.0 (55.0–65.5) | 0.108 | |
| Male (Sex) | 83.9 | 85.0 | 0.939 | |
| Smoking | 29.5 | 20.6 | 0.141 | |
| Hypertension | 49.0 | 66.4 | 0.008 | |
| Diabetes mellitus | 28.2 | 39.3 | 0.085 | |
| Chronic kidney disease | 5.4 | 4.7 | >0.999 | |
| Dyslipidemia | 29.5 | 34.6 | 0.471 | |
| Cerebrovascular accident | 2.7 | 0.0 | 0.231 | |
| Previous PCI | 16.8 | 31.8 | 0.008 | |
| Previous MI | 10.7 | 14.0 | 0.549 | |
| Previous CABG | 1.3 | 1.9 | >0.999 | |
| Left ventricular ejection fraction (%) | 64.0 (59.0–69.0) | 64.0 (59.0–67.0) | 0.598 | |
| Baseline ECG abnormalities* | 4.1 | 8.4 | 0.234 | |
| Medications at discharge | ||||
| Beta blockers | 53.0 | 56.1 | 0.721 | |
| Calcium channel blockers | 34.2 | 34.6 | >0.999 | |
| Other vasodilators† | 11.4 | 12.1 | >0.999 | |
| Trimetazidine | 3.4 | 1.9 | 0.741 | |
| Aspirin | 99.3 | 95.3 | 0.095 | |
| Clopidogrel | 98.7 | 100.0 | 0.629 | |
| Medications during follow-up period | ||||
| Beta blockers | 55.7 | 58.9 | 0.705 | |
| Calcium channel blockers | 33.6 | 42.1 | 0.209 | |
| Other vasodilators | 14.1 | 13.1 | 0.962 | |
| Trimetazidine | 6.0 | 10.3 | 0.312 | |
| Any antiplatelet agent | 100.0 | 100.0 | >0.999 | |
Values are presented as mean±standard deviation or median (Q1–Q3) or percentage as appropriate.
CABG = coronary artery bypass grafting; CR = complete revascularization; ECG = electrocardiogram; IR = incomplete revascularization; MI = myocardial infarction; PCI = percutaneous coronary intervention.
*Atrial fibrillation left ventricular hypertrophy, ST/T segment changes, and bundle branch block; †Nicorandil, isosorbide mononitrate, isosorbide dinitrate, and molsidomine.
Angiographic and procedural characteristics
| Variables | Functional CR group (n=149) | Functional IR group (n=107) | p value | ||
|---|---|---|---|---|---|
| Angiographic characteristics | |||||
| Disease extent | 0.510 | ||||
| Left main only | 0.7 | 1.9 | |||
| 1 vessel disease | 43.6 | 35.5 | |||
| 2 vessel disease | 34.2 | 39.3 | |||
| 3 vessel disease | 21.5 | 23.4 | |||
| SYNTAX score | 11.0 (8.0–19.0) | 13.0 (9.0–20.2) | 0.256 | ||
| Percutaneous coronary intervention | |||||
| Left anterior descending artery | 63.8 | 61.7 | 0.835 | ||
| Left circumflex artery | 31.5 | 39.3 | 0.252 | ||
| Right coronary artery | 34.2 | 32.7 | 0.905 | ||
| At least 1 bifurcation lesion | 23.5 | 23.4 | >0.999 | ||
| At least 1 CTO lesion | 20.8 | 15.9 | 0.405 | ||
| At least 1 B2/C lesion | 53.7 | 60.7 | 0.319 | ||
| Use of IVUS or OCT | 28.2 | 29.0 | >0.999 | ||
| Stent profiles | |||||
| No. of stents used | 1.0 (1.0–2.0) | 1.0 (1.0–2.0) | 0.568 | ||
| Total length of stents, mm | 28.0 (20.0–48.0) | 30.0 (23.0–51.0) | 0.560 | ||
| Mean diameter of stents, mm | 3.2 (2.9–3.5) | 3.0 (2.8–3.5) | 0.024 | ||
| Stent type | 0.713 | ||||
| First-generation only | 49.7 | 53.3 | |||
| Second-generation only | 47.7 | 43.0 | |||
| Others* | 2.7 | 3.7 | |||
| Residual disease | 0.052 | ||||
| Residual SYNTAX score | 2.0 (0.0–8.0) | 5.0 (0.0–11.0) | |||
Values are presented as mean±standard deviation or median (Q1–Q3) or percentage as appropriate.
CR = complete revascularization; CTO = chronic total occlusion; IR = incomplete revascularization; IVUS = intravascular ultrasound; OCT = optical coherence tomography; SYNTAX = Synergy between PCI with Taxus and Cardiac Surgery.
*Others included simultaneous use of bare metal, first-generation, or second-generation stents.
Results of exercise stress testing before and after revascularization
| Variables | Before revascularization | After revascularization | |||||
|---|---|---|---|---|---|---|---|
| Functional CR group (n=149) | Functional IR group (n=107) | p value | Functional CR group (n=149) | Functional IR group (n=107) | p value | ||
| Exercise-induced chest pain | 0.156 | <0.001 | |||||
| Limiting chest pain | 38.3 | 29.9 | 2.0 | 15.0 | |||
| Non-limiting chest pain | 33.6 | 30.8 | 4.0 | 21.5 | |||
| No pain | 28.2 | 39.3 | 94.0 | 63.6 | |||
| ST change during exercise | 0.154 | <0.001 | |||||
| No ST change | 0.0 | 0.0 | 100.0 | 0.0 | |||
| ST depression 1–2 mm | 91.9 | 91.6 | 0.0 | 94.4 | |||
| ST depression >2 mm | 5.4 | 8.4 | 0.0 | 4.7 | |||
| ST elevation ≥1 mm | 2.7 | 0.0 | 0.0 | 0.9 | |||
| Exercise duration (seconds) | 540 (414, 602) | 480 (402, 589) | 0.091 | 612 (540, 661) | 540 (441, 600) | <0.001 | |
| Change (seconds) | 62.0 (12.0, 141.0) | 30.0 (−11.0, 103.5) | 0.011 | ||||
| Change (%) | 12.0 (2.0, 33.5) | 6.8 (−2.0, 23.9) | 0.028 | ||||
| Duke treadmill score | −4.3±5.0 | −5.2±5.4 | 0.201 | 9.0±2.8 | −1.4±5.2 | <0.001 | |
| Change | 13.3±5.1 | 4.0±6.1 | <0.001 | ||||
Values are presented as mean±standard deviation or median (Q1–Q3) or percentage as appropriate.
CR, complete revascularization; IR, incomplete revascularization.
Figure 1Exercise duration according to functional completeness of revascularization. (A) Exercise duration before PCI; (B) Exercise duration after PCI; (C) Changes in exercise duration after PCI.
CR = complete revascularization; IR = incomplete revascularization; PCI = percutaneous coronary intervention.
Figure 2Changes of exercise duration after PCI according to pre-PCI functional and anatomical severity. (A) Pre-PCI Duke treadmill score and changes of exercise duration; (B) Pre-PCI SYNTAX score and changes in exercise duration. Correlation coefficient (beta) was adjusted for age, sex, hypertension, diabetes mellitus, previous percutaneous coronary intervention and previous myocardial infarction.
PCI = percutaneous coronary intervention; SYNTAX = Synergy Between PCI With Taxus and Cardiac Surgery.
Figure 3Comparison of risk of major adverse cardiac events at 3 years. Hazard ratio and its p value were adjusted for age, sex, hypertension, diabetes mellitus, previous percutaneous coronary intervention and previous myocardial infarction.
CI = confidence interval; CR = complete revascularization; HRadj = adjusted hazard ratio; IR = incomplete revascularization.
Clinical outcomes at 3 years after revascularization
| Outcomes | Functional CR group (n=149) | Functional IR group(n=107) | Unadjusted HR | p value | Adjusted HR* | p value |
|---|---|---|---|---|---|---|
| Major adverse cardiac events | 9 (6.2) | 27 (26.1) | 0.21 (0.10–0.45) | <0.001 | 0.18 (0.08–0.40) | <0.001 |
| All-cause death | 2 (1.4) | 1 (1.0) | 1.35 (0.12–14.90) | 0.806 | 1.47 (0.12–17.59) | 0.759 |
| MI | 2 (1.4) | 1 (1.0) | 1.35 (0.12–14.74) | 0.806 | 0.83 (0.07–10.03) | 0.886 |
| Ischemia-driven revascularization | 7 (4.8) | 26 (25.1) | 0.17 (0.07–0.39) | <0.001 | 0.15 (0.06–0.34) | <0.001 |
Values are number (%) or HR (95% confidential interval).
CR = complete revascularization; HR = hazard ratio; IR = incomplete revascularization; MI = myocardial infarction.
*Adjusted HR was calculated by multivariate Cox regression analyses with age, sex, hypertension, diabetes mellitus, previous percutaneous coronary intervention and previous MI.